Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.75
+0.03 (0.31%)
At close: Aug 11, 2026, 4:00 PM EDT
9.74
-0.01 (-0.10%)
After-hours: Aug 11, 2026, 7:34 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.33 billion as of August 11, 2026. Its market cap has increased by 77.40% in one year.
Market Cap
1.33B
Enterprise Value
826.98M
1-Year Change
77.40%
Ranking
Category
Stock Price
$9.75
ChartMarket Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.33B, an increase of 672.50%. That is a compound annual growth rate of 30.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 1.33B | -5.34% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 1.43B |
| ORIC Pharmaceuticals | 1.41B |
| Inhibrx Biosciences | 1.37B |
| Monte Rosa Therapeutics | 1.35B |
| Aktis Oncology | 1.33B |
| LB Pharmaceuticals | 1.31B |
| Novavax | 1.30B |
| Jade Biosciences | 1.29B |